[Effects of lamivudine and thymosin alpha1 combination therapy on patients with chronic hepatitis B].

Plain Language Summary

This study investigated the effects of combining lamivudine and thymosin alpha-1 for treating chronic hepatitis B patients. While the detailed results are not available in English, the research contributes to the growing body of evidence exploring combination approaches that pair antiviral drugs with immune-boosting peptides for more effective hepatitis B treatment.